171 related articles for article (PubMed ID: 29575648)
21. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
22. Simulating PDGF-Driven Glioma Growth and Invasion in an Anatomically Accurate Brain Domain.
Massey SC; Rockne RC; Hawkins-Daarud A; Gallaher J; Anderson ARA; Canoll P; Swanson KR
Bull Math Biol; 2018 May; 80(5):1292-1309. PubMed ID: 28842831
[TBL] [Abstract][Full Text] [Related]
23. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.
Lindberg N; Kastemar M; Olofsson T; Smits A; Uhrbom L
Oncogene; 2009 Jun; 28(23):2266-75. PubMed ID: 19421151
[TBL] [Abstract][Full Text] [Related]
24. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
[TBL] [Abstract][Full Text] [Related]
25. Transposon mutagenesis identifies genes that transform neural stem cells into glioma-initiating cells.
Koso H; Takeda H; Yew CC; Ward JM; Nariai N; Ueno K; Nagasaki M; Watanabe S; Rust AG; Adams DJ; Copeland NG; Jenkins NA
Proc Natl Acad Sci U S A; 2012 Oct; 109(44):E2998-3007. PubMed ID: 23045694
[TBL] [Abstract][Full Text] [Related]
26. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.
Daginakatte GC; Gutmann DH
Hum Mol Genet; 2007 May; 16(9):1098-112. PubMed ID: 17400655
[TBL] [Abstract][Full Text] [Related]
27. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment.
Fomchenko EI; Holland EC
Neurosurg Clin N Am; 2007 Jan; 18(1):39-58, viii. PubMed ID: 17244553
[TBL] [Abstract][Full Text] [Related]
29. Sleeping Beauty mouse models identify candidate genes involved in gliomagenesis.
Vyazunova I; Maklakova VI; Berman S; De I; Steffen MD; Hong W; Lincoln H; Morrissy AS; Taylor MD; Akagi K; Brennan CW; Rodriguez FJ; Collier LS
PLoS One; 2014; 9(11):e113489. PubMed ID: 25423036
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
31. Identifying candidate genes involved in brain tumor formation.
Johansson Swartling F
Ups J Med Sci; 2008; 113(1):1-38. PubMed ID: 18521796
[TBL] [Abstract][Full Text] [Related]
32. Changes in Skeletal Muscle and Body Weight on Sleeping Beauty Transposon-Mediated Transgenic Mice Overexpressing Pig mIGF-1.
Gao B; Wang W; Wu H; Chen C; Shen D; Wang S; Chen W; Zhang L; Chan S; Song C
Biochem Genet; 2018 Aug; 56(4):341-355. PubMed ID: 29470680
[TBL] [Abstract][Full Text] [Related]
33. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
Rahme GJ; Luikart BW; Cheng C; Israel MA
Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807
[TBL] [Abstract][Full Text] [Related]
34. CCAAT/enhancer-binding protein delta regulates the stemness of glioma stem-like cells through activating PDGFA expression upon inflammatory stimulation.
Wang SM; Lin HY; Chen YL; Hsu TI; Chuang JY; Kao TJ; Ko CY
J Neuroinflammation; 2019 Jul; 16(1):146. PubMed ID: 31300060
[TBL] [Abstract][Full Text] [Related]
35. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
[TBL] [Abstract][Full Text] [Related]
36. De novo induction of genetically engineered brain tumors in mice using plasmid DNA.
Wiesner SM; Decker SA; Larson JD; Ericson K; Forster C; Gallardo JL; Long C; Demorest ZL; Zamora EA; Low WC; SantaCruz K; Largaespada DA; Ohlfest JR
Cancer Res; 2009 Jan; 69(2):431-9. PubMed ID: 19147555
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic Transition as a Survival Strategy of Glioma.
Ichikawa T; Otani Y; Kurozumi K; Date I
Neurol Med Chir (Tokyo); 2016 Jul; 56(7):387-95. PubMed ID: 27169497
[TBL] [Abstract][Full Text] [Related]
38. Persistent roles of signal transduction of platelet-derived growth factor B in genesis, growth, and anaplastic transformation of gliomas in an in-vivo serial transplantation model.
Torisu R; Suzuki SO; Masui K; Yoshimoto K; Mizoguchi M; Hashizume M; Canoll P; Goldman JE; Sasaki T; Iwaki T
Brain Tumor Pathol; 2011 Feb; 28(1):33-42. PubMed ID: 21210235
[TBL] [Abstract][Full Text] [Related]
39. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
40. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
